Company profiles
 |
|
 Merck KGaA | Frankfurter Str. 250 | Postcode: F135/101 | 64293 Darmstadt | Germany
E-mail: globalmeded@merckgroup.com
Contact person: Erin Pascal
|
Merck is a leading science and technology company in healthcare, life science and performance materials. Around 50,000 employees work to further develop technologies that improve and enhance life - from biopharmaceutical therapies to treat cancer or multiple sclerosis, cutting-edge systems for scientific research and production, to liquid crystals for smartphones and LCD televisions. In 2015, Merck generated sales of € 12.85 billion in 66 countries. Founded in 1668, Merck is the world's oldest pharmaceutical and chemical company. The founding family remains the majority owner of the publicly listed corporate group. Merck, Darmstadt, Germany holds the global rights to the Merck name and brand. The only exceptions are the United States and Canada, where the company operates as EMD Serono, MilliporeSigma and EMD Performance Materials. |
 |
|
 Novartis
Website: www.novartis.com
|
Novartis provides innovative healthcare solutions that address the evolving needs of patients and societies. Headquartered in Basel, Switzerland, Novartis offers a diversified portfolio to best meet these needs: innovative medicines, cost-saving generic and biosimilar pharmaceuticals and eye care. Novartis has leading positions globally in each of these areas. In 2016, the Group achieved net sales of USD 48.5 billion, while R&D throughout the Group amounted to approximately USD 9.0 billion. Novartis Group companies employ approximately 118,000 full-time-equivalent associates. Novartis products are sold in approximately 155 countries around the world. |
 Sanofi Genzyme
500 Kendall Street,
Cambridge, MA 02142
USA
VP Media Relations
Website: www.genzyme.com
Contact person: Erin Pascal
|
Sanofi, a global healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients' needs. Sanofi is organized into five global business units: Diabetes and Cardiovascular, General Medicines and Emerging Markets, Sanofi Genzyme, Sanofi Pasteur and Merial. Sanofi is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY). Sanofi Genzyme focuses on developing specialty treatments for debilitating diseases that are often difficult to diagnose and treat, providing hope to patients and their families. Learn more at www.sanofigenzyme.com |
 Sunovion Pharmaceuticals Inc.
84 Waterford Drive
Marlborough, MA 01752
Telephone: 508-481-6700
|
Sunovion is a global biopharmaceutical company focused on the innovative application of science and medicine to help people with serious medical conditions. Sunovion’s spirit of innovation is driven by the conviction that scientific excellence paired with meaningful advocacy and relevant education can improve lives. The Company has charted new paths to life-transforming treatments that reflect ongoing investments in research and development and an unwavering commitment to support people with psychiatric, neurological, and respiratory conditions. |
 |
|
 GE Healthcare
Pollards Wood Chalfont, St Giles Bucks HP8 4SP UK Telephone: +44 1494 544000 |
GE Healthcare provides transformational medical technologies and services
to meet the demand for increased access, enhanced quality and more
affordable healthcare around the world. GE (NYSE: GE) works on things that
matter - great people and technologies taking on tough challenges.
From medical imaging, software & IT, patient monitoring and diagnostics to drug discovery, biopharmaceutical manufacturing technologies and performance improvement solutions, GE Healthcare helps medical professionals deliver great healthcare to their patients. |
 |
|
 Daiichi Sankyo Europe GmbH Zielstattstr. 48 81379 Munich Germany Telephone: +49 89 78080
Fax: +49 89 7808267 Website: www.daiichi-sankyo.eu |
About Daiichi Sankyo
Daiichi Sankyo Group is dedicated to the creation and supply of innovative pharmaceutical products to address diversified, unmet medical needs of patients in both mature and emerging markets. With over 100 years of scientific expertise and a presence in more than 20 countries, Daiichi Sankyo and its 17,000 employees around the world draw upon a rich legacy of innovation and a robust pipeline of promising new medicines to help people. In addition to its strong portfolio of medicines for hypertension, dyslipidemia, bacterial infections, and thrombotic disorders, the Group's research and development is focused on bringing forth novel therapies in cardiovascular-metabolic diseases, pain management, and oncology, including biologics. For more information, please visit: www.daiichisankyo.com About Daiichi Sankyo Europe
Daiichi Sankyo's European base is located in Munich and has affiliates in 12 European countries in addition to a global manufacturing site located in Pfaffenhofen, Germany. For more information, please visit: www.daiichi-sankyo.eu |
 LivaNova PLC 20 Eastbourne Terrace
London, W2 6LG
|
LivaNova exists at the intersection of advancing technology and transforming lives for people impacted by cardiopulmonary diseases, cardiac rhythm disorders, and the management of refractory epilepsy and treatment-resistant depression. With a presence in more than 100 countries, LivaNova operates as three business units that develop, manufacture, and market medical technologies for Cardiac Rhythm Management, Cardiac Surgery, and Neuromodulation, with operating headquarters in Clamart, France, Mirandola, Italy, and Houston, Texas, United States, respectively. We develop and deliver innovative solutions today for better health tomorrow. Day by day. Life by life. |
 Teva |
Teva is among the top 15 global pharmaceutical companies globally, delivering high-quality, patientcentric healthcare solutions used by approximately 200 million patients in 100 markets every day. Teva produces a leading treatment for multiple sclerosis and has late-stage development programs for a range of disorders of the central nervous system, including movement disorders, migraine, pain and neurodegenerative conditions. With its European headquarters in Amsterdam, the Netherlands, Teva is the world’s largest generic medicines producer, leveraging its portfolio of more than 1,800 molecules to produce a broad range of products in nearly every therapeutic area. Teva draws on its specialty and generics capabilities to seek new ways of addressing unmet patient needs by combining drug development with devices, services and technologies. Teva's net revenues in 2016 were $21.9 billion. |
|
|
|
 BIAL Headquarters
À Avenida da Siderurgia Nacional
4745-457 Coronado (S. Romão e S. Mamede) - Portugal Phone: + 351 22 986 6100
Email: info@bial.com
Website: www.bial.com
|
BIAL is an international pharmaceutical company strongly committed to innovation. Founded in 1924, BIAL's mission is to discover, develop and provide new therapeutic solutions.
Consistently investing more than 20% of its turnover in Research and Development (R&D), BIAL has established an ambitious R&D program centred on the central nervous, cardiovascular system and allergy immunotherapy. The company has developed an antiepileptic drug, (Zebinix - eslicarbazepine acetate) already commercialized in the US market and in several European countries. A second compound from its R&D pipeline for the treatment of Parkinson's disease, Opicapone, is under review by the European Medicines Agency. |
.png){kind=logo} |
MedImmune is the global biologics research and development arm of AstraZeneca, a global, innovation-driven biopharmaceutical business that focuses on the discovery, development and commercialization of small molecule and biologic prescription medicines. MedImmune is pioneering innovative research and exploring novel pathways across key therapeutic areas, including respiratory, inflammation and autoimmunity; cardiovascular and metabolic disease; oncology; neuroscience; and infection and vaccines. The MedImmune headquarters is located in Gaithersburg, Md., one of AstraZeneca's three global R&D centers, with additional sites in Cambridge, UK and Mountain View, CA.
|
To learn more about MS in the 21st Century, please contact the secretariat at: msin21stcentury@is-health.co.uk
|
MS in the 21st Century is a Merck-sponsored initiative, comprising a steering group of MS experts and patient advocates. Merck KGaA, Darmstadt, Germany, is a leading science and technology company in healthcare, life science and performance materials. Around 50,000 employees work to further develop technologies that improve and enhance life – from biopharmaceutical therapies to treat cancer or multiple sclerosis, to cutting-edge systems for scientific research and production. Founded in 1668, Merck KGaA, is the world's oldest pharmaceutical and chemical company and the founding family remains the majority owner of the publicly listed corporate group. |
 Takeda Pharmaceuticals International GmbH
Singapore Branch
21 Biopolis Road,
|
Located in Osaka, Japan, Takeda is a research-based global company with its main focus on pharmaceuticals. As the largest pharmaceutical company in Japan and one of the global leaders of the industry, Takeda is committed to strive towards better health for people worldwide through leading innovation in medicine. |
|
|
|
AbbVie Pharmaceuticals S.A. |
AbbVie is a global, research-based biopharmaceutical company formed in 2013 following separation from Abbott Laboratories. The company's mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world's most complex and serious diseases. Together with its wholly-owned subsidiary, Pharmacyclics, AbbVie employs more than 28,000 people worldwide and markets medicines in more than 170 countries. |
 Itamar Medical
9 Halamish Street Caesarea industrial zone Caesarea 3088900 Telephone: +972-4 6177000 Fax: +972-4-6238071 Email: info@itamar-medical.com Website: www.itamar-medical.com |
Itamar Medical a medical device company focused on leading the integration of Sleep Apnea management into the cardiac patient care pathway. Core strategies include the development, manufacturing and sales of the WatchPAT™ diagnostic product line based on the proprietary PAT signal that was proven as a simple, comprehensive, reliable and scalable alternative to airflow and it enables point-of-deployment versatility. Total Sleep Solution – a product that includes a field support organization, partnerships, core and supporting technologies that enable all physicians in general and Cardiologists in particular to collaborate with sleep specialists and provide a seamless and full continuum of care to Sleep Apnea patients as part of their care pathway. |
 Eli Lilly and Company
Lilly Corporate Center Indianapolis, IN 46285 U.S.A. +1.317.276.2000 Website: www.lilly.com |
For 140 years, we have worked tirelessly to develop and deliver trusted medicines that meet real needs, finding ways to come through no matter the odds. From the development of insulin to the discovery of new treatments for mental illness, we have pioneered breakthroughs against some of the most stubborn and devastating diseases. We bring this same determination to our work today, uniting our expertise with the creativity of research partners across the globe to keep finding ways to make life better. |
 VIVISOL
Postbus 4270
5004JG Tilburg, Nederland
Telephone: +31 (0) 13 5231020
Fax: +31 (0) 13 5231029
Email info@vivisol.nl
|
VIVISOL is one of the premier European groups working in the home care sector, specialised in respiratory care, (in particular diagnosis, care of OSAS, oxygen therapy, mechanical ventilation) and also provide services in the fields of woundcare and telemedicine.
VIVISOL constantly focusses on developing, evolving and refining our respiratory care solutions through evaluation, assessment and comparison of the different options available in the healthcare sector. We aim to provide patients with the best service possible.
Hence, VIVISOL focuses on "IMPROVING THE QUALITY OF LIFE" of chronic patients, whose therapy is delivered at home or in comfortable residential facilities.
|
|
|
|
 Brain Therapeutics
8, Eptanissou str. 16341 Ilioupolis Athens, Greece Phone: +302109931458 Email: info@braintherapeutics.gr Website: www.braintherapeutics.gr Contact person: George Pavlakis |
Brain Therapeutics is a Central Nervous System Specialty Company focused on three Therapeutic areas: Psychiatry, Neurology and Pain. Brain Therapeutics specializes in in-licensing and commercializing approved products from Central Nervous System Sector to address the unmet medical needs of patients with Brain Disorders, such as Mood and Anxiety diseases, Schizophrenia and Bipolar Disorder, Parkinson’s and Epilepsy, as well as Pain. Our mission is to become the uniquely qualified partner of choice for CNS pharmaceutical companies seeking trusted CNS business partner locally or regionally. We are fully committed to bring innovative treatments for patients suffering from Brain Diseases. |
 CEFALY-Technology
Rue de Wallonie, 11 4460 Grâce-Hollogne Belgium Phone: +32 4 367 67 22 Email: info@cefaly.com Website: www.cefalytechnology.com Contact person: Raphael Ravet |
CEFALY Technology has developed a unique medical device for the prevention of migraines called Cefaly®, which is the first device of its kind to receive FDA approval in March 2014. The company’s mission is to research and develop non- invasive, drug-free, medical treatments for neurological diseases. In addition to Cefaly®, the company is also leading research using medical devices for the treatments of coma, epilepsy, and fibromyalgia. |
 |
CeGaT GmbH is a Germany-based sequencing service provider specialized in supplying high-standard molecular diagnostics. All steps, from patient and family consultation to examination, genetic testing, and creation of medical reports are carried out by our team of experts in-house. The medical report provides the attending physician with a detailed diagnosis and support for further treatment decisions. Furthermore, CeGaT offers customized sequencing solutions for researchers and clinical scientist around the globe for realizing their research projects. Therefore we utilize a combination of both conventional and next-generation sequencing techniques to provide the best-possible service for patients and doctors. |
|
|
|
 Wisepress Medical Bookshop
25 High Path, Merton Abbey,
London, SW19 2JL UK
Telephone: +44 20 8715 1812
|
Wisepress.com, Europe's leading conference bookseller, has a range of books and journals relevant to the themes of the meeting. In addition to attending 200 conferences per year, Wisepress has a comprehensive medical and scientific bookshop online with great offers. Follow us on Twitter for the latest news @WisepressBooks. |
